Biocon Ltd.
Snapshot View

289.10 +2.25 ▲0.8%

30 September 2022, 11:18:58 AM
Volume: 968,991

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biocon.com
Market Cap 34,445.21 Cr.
Enterprise Value(EV) 37,601.71 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 5.90 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 48.62 Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 70.28 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.08 Calculated using Price: 286.90
Dividend Yield 0.17 Period Ending 2022-03
No. of Shares Subscribed 120.06 Cr. 1,200,600,000 Shares
FaceValue 5
Company Profile
The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.78%
1 Week
+1.87%
1 Month
-6.71%
3 Month
-6.26%
6 Month
-15.36%
1 Year
-20.29%
2 Year
-35.43%
5 Year
+74.07%
10 Year
+531.22%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 17.22 16.31 15.37 8.74 18.00 14.26 13.16 12.47
Return on Capital Employed (%) 15.75 15.30 13.93 12.59 8.92 16.11 14.35 11.30 9.93
Return on Assets (%) 8.47 8.72 7.96 7.64 4.55 9.25 6.94 5.73 5.11

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2,695 3,027 3,271 4,034 4,838 5,181 6,098 6,706 7,627 8,433
Non Curr. Liab. 666 1,262 1,378 2,421 2,305 2,007 2,122 2,685 5,497 6,803
Curr. Liab. 990 1,380 1,555 1,666 1,678 2,141 3,039 4,008 4,210 3,828
Minority Int. 65 82 172 266 376 468 609 677 881 1,038
Equity & Liab. 4,416 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101
Non Curr. Assets 2,176 3,112 3,813 4,416 5,149 5,648 6,979 8,751 10,614 11,718
Curr. Assets 2,240 2,639 2,563 3,971 4,048 4,149 4,889 5,325 7,600 8,382
Misc. Exp. not W/O
Total Assets 4,416 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 2,877 3,090 3,347 3,891 4,123 5,514 6,301 7,143 8,184 8,563
Other Income 56 53 84 157 206 414 508 605 689 298
Total Income 2,933 3,143 3,431 4,048 4,330 5,929 6,808 7,748 8,873 8,861
Total Expenditure -2,190 -2,394 -2,584 -2,912 -3,294 -4,391 -5,044 -5,841 -6,690 -6,638
PBIDT 743 749 847 1,137 1,035 1,538 1,765 1,907 2,183 2,224
Interest -2 -9 -29 -26 -62 -71 -65 -58 -68 -68
Depreciation -204 -221 -249 -277 -385 -448 -552 -715 -814 -837
Taxation -107 -96 -142 -162 -157 -212 -315 -222 -212 -184
Exceptional Items 105 161 195 68 13 -111 -111
PAT 431 528 587 672 432 1,002 900 926 979 1,024
Minority Interest -17 -31 -59 -76 -81 -97 -123 -106 -123 -122
Share Associate 22 16 21 1 -29 -79 -207 -194
Other Related Items
Consolidated Net Profit 414 497 550 612 372 905 748 741 648 708
Adjusted EPS 3 4 5 5 3 8 6 6 5 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 471 561 211 371 640 662 1,155 1,283 1,160 1,177
Cash Fr. Inv. -376 -938 -509 -1,142 -499 -684 -714 -1,559 -3,625 -1,699
Cash Fr. Finan. -9 426 186 1,068 -178 -240 -242 388 2,564 242
Net Change 87 49 -112 297 -36 -262 199 112 99 -280
Cash & Cash Eqvt 474 557 463 758 710 449 659 825 897 654

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 60.67 60.67 60.67 60.67 60.64 60.64 60.64 60.64 60.64
Public 39.33 39.33 39.33 39.33 39.36 39.36 39.36 39.36 39.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 29 Sep 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Biocon Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call
Wed, 28 Sep 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Biocon Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call
Tue, 27 Sep 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Biocon Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Thu, 29 Sep 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
CCI Bullish CCI Bullish
Short Cover Short Cover
Aggressive Short Cover Aggressive Short Cover

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 933.65 +0.3%
Divi's Laboratories Ltd. 97,819.86 3,676.50 -0.5%
Cipla Ltd. 90,339.79 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. 52,359.20 1,546.05 +0.0%
Abbott India Ltd. 40,610.60 19,160.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-06 36.30 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-06 50.22 19,160.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-06 4.20 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-06 13.62 19,160.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-03 0.00 19,160.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-03 29.95 19,160.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-03 29.95 19,160.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,160.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 933.65 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,676.50 -0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,295.00 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,404.75 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,546.05 +0.0%
Abbott India Ltd. Standalone 2022-03 798.70 19,160.00 -0.1%

FAQ's On Biocon Ltd.

What is Biocon share price?

Can I buy Biocon shares now?

What is the Dividend Yield of Biocon?

What is the Market Cap of Biocon?

What are the key metrics to analyse Biocon?

What is the 52 Week High and Low of Biocon?

What is the trend of Biocon share price?